Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Abramson Cancer Center at Penn Medicine
Seoul National University Hospital
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
SWOG Cancer Research Network
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Wisconsin, Madison
University of Maryland, Baltimore
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of Washington
OHSU Knight Cancer Institute
European Mantle Cell Lymphoma Network
Alliance for Clinical Trials in Oncology
French Innovative Leukemia Organisation
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
French Innovative Leukemia Organisation